All In MedTech

Device Trial Radar · NCT04285060

Safety and Efficacy of Samsung GEMS-H Device Training in Sub-Acute and Chronic Stroke

Safety and Efficacy on Functional Mobility Following Samsung GEMS-H Device Training in Sub-Acute and Chronic Stroke: A Pivotal Study

Last checked: Nov 19, 2026Latest source record: Sep 27, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingTitle says "pivotal". This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

100

Planned (sponsor's estimate)

Start

Feb 12, 2020

Primary completion

Nov 2021

Study completion Dec 2021

Sponsor

Lead sponsor
Samsung ElectronicsNot on our public-company list
Sponsor type
Industry
Collaborators
Shirley Ryan AbilityLab
First posted
Feb 26, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A single-site, interventional, single-arm trial to evaluate the safety and efficacy on functional mobility following Samsung GEMS-H (Gait Enhancing and Motivating System - Hip) device training in participants with sub-acute and chronic stroke.

Conditions

  • Stroke
  • Chronic Stroke

Interventions

  • Samsung GEMS-HDevice

    Subjects will participate in 18 sessions of training in the outpatient clinic with a licensed physical therapist. Therapy sessions will include 30 minutes of task specific training and another 15 minutes of the session can be used to focus on patient specific goal areas related to functional mobility and balance. Training sessions will occur 2-3 times a week for 6-8 weeks to complete the training protocol.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of device related adverse eventsTime frame: Duration of study participation (estimated 6 months)
  2. 10 Meter Walk Test (Self-selected walking speed) (10MWT-SS)Time frame: Baseline, Post-Intervention (estimated 8 weeks)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shirley Ryan AbilityLab

    Chicago, Illinois · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.